About 16,000 results
Open links in new tab
  1. Biotech and Pharma Industry News | BioPharma Dive

    Dec 5, 2025 · BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, …

  2. Biotech News | BioPharma Dive

    6 days ago · The latest biotech news for biopharmaceutical professionals

  3. Pharma News | BioPharma Dive

    Dec 9, 2025 · The latest pharma news for biotech and biopharmaceutical professionals

  4. Deep Dive - BioPharma Dive

    Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a digital divide between highly resourced health systems and safety-net providers ...

  5. The biopharma industry outlook on 2025: Uncertainty and change

    Jan 24, 2025 · The biopharma industry outlook on 2025: Uncertainty and change The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as …

  6. Clinical Trial News | BioPharma Dive

    2 days ago · The latest clinical trial news for biotech and biopharmaceutical professionals

  7. 10 clinical trials to watch the rest of 2025 | BioPharma Dive

    Jan 2, 2025 · 10 clinical trials to watch the rest of 2025 Expected readouts in obesity, lung cancer and atopic dermatitis headline a series of study results that could give the biotechnology sector a boost in …

  8. Biotech's M&A outlook is uncertain. Track the deals ... - BioPharma Dive

    3 days ago · Including Sobi's acquisition of Arthrosi, the last three biotech M&A deals have all involved privately held drug startups.

  9. Gene Therapy News | BioPharma Dive

    3 days ago · The latest gene therapy news for biotech and biopharmaceutical professionals

  10. 5 questions facing emerging biotech in 2025 | BioPharma Dive

    Jan 14, 2025 · 5 questions facing emerging biotech in 2025 Competition from China and a barely open “IPO window” are among the challenges confronting young drugmakers this year.